NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
school
University Rankings
subject
University Subject Rankings
place
Country Rankings
insights
i10 Productivity Rankings
insights
Subject Rankings
format_list_numbered
Top 100 Scientists
format_list_numbered
Citation Rankings
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Paul A Vanderlaan
AD Scientific Index 2024
Medical and Health Sciences / Pathology
Harvard University - Cambridge / United States
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Paul A Vanderlaan's MOST POPULAR ARTICLES
1-)
The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria, and Explanatory NotesSZ Ali, PA VanderLaan1170*2003
2-)
Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulatorsPA VanderLaan, CA Reardon, GS GetzArteriosclerosis, thrombosis, and vascular biology 24 (1), 12-22, 20048282004
3-)
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancerMJ Niederst, LV Sequist, JT Poirier, CH Mermel, EL Lockerman, ...Nature communications 6 (1), 6377, 20155892015
4-)
Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancersD Rangachari, N Yamaguchi, PA VanderLaan, E Folch, A Mahadevan, ...Lung cancer 88 (1), 108-111, 20154712015
5-)
Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach?PA VanderLaan, E Marqusee, JF KraneAmerican Journal of Clinical Pathology 135 (5), 770-775, 20112522011
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept